STgen Bio to invest W110b to boost capacity for global expansion

STgen Bio announced Thursday that it will expand its first plant to meet rising demand for high-titer biopharmaceuticals. This capacity boost involves adding midsize facilities suitable for multiproduct production, aimed at expanding the company’s business portfolio and securing global orders. The investment of approximately 110 billion won ($77 million) will be used to expand drug substance and drug product production facilities and establish related infrastructure. Production capacity will inc

By The Korea Herald